PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19153267-6	2009	In contrast, we observed increased TGF-beta activity, again more marked in the monocrotaline model, as evidenced by increased phospho-Smad2/3 and increased expression of TGF-beta-regulated genes.	Monocrotaline	79-92	transforming growth factor, beta 1	Rattus norvegicus	35-43	
19153267-12	2009	Increased TGF-beta activity is associated with greater macrophage recruitment with monocrotaline treatment.	Monocrotaline	83-96	transforming growth factor, beta 1	Rattus norvegicus	10-18	
17506718-6	2007	TGFbeta was depressed at 28 days by MCT, an effect reversed by a combination of captopril and RA.	Monocrotaline	36-39	transforming growth factor, beta 1	Rattus norvegicus	0-7	
31956132-8	2020	AOS treatment also prevented MCT-induced pulmonary vascular remodeling via inhibition of the TGF-beta1/p-Smad2 signaling pathway.	Monocrotaline	29-32	transforming growth factor, beta 1	Rattus norvegicus	93-102	
33760143-0	2021	Cyanidin-3-O-beta-glucoside protects against pulmonary artery hypertension induced by monocrotaline via the TGF-beta1/p38 MAPK/CREB signaling pathway.	Monocrotaline	86-99	transforming growth factor, beta 1	Rattus norvegicus	108-117	
31922224-9	2020	The results demonstrated that FMN significantly alleviated the changes of hemodynamics and pulmonary vascular morphology, and decreased the MCT-induced upregulations of TGFbeta1, MMP2 and MMP9 expression levels.	Monocrotaline	140-143	transforming growth factor, beta 1	Rattus norvegicus	169-177	
23418342-8	2013	Finally, in a monocrotaline-induced rat model of PAH, which is associated with increased TGF-beta signaling, this study confirms that treprostinil, a stable prostacyclin analog, inhibits the TGF-beta pathway by reducing SMAD3 phosphorylation.	Monocrotaline	14-27	transforming growth factor, beta 1	Rattus norvegicus	89-97	
23418342-8	2013	Finally, in a monocrotaline-induced rat model of PAH, which is associated with increased TGF-beta signaling, this study confirms that treprostinil, a stable prostacyclin analog, inhibits the TGF-beta pathway by reducing SMAD3 phosphorylation.	Monocrotaline	14-27	transforming growth factor, beta 1	Rattus norvegicus	191-199